Developer docs
API playgroundTry for free, no card

Search company profiles

Bravado Health

Full company profile

uuid0003v8a

Namestring
Bravado Health
Legal namestring
PRN Software, LLC
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Bravado Health (operating through its legal entity PRN Software, LLC and trade names TreatRx and DoseSpot) is a US-based healthcare IT company that provides a standalone, cloud-based electronic prescribing (ePrescribing) platform. Founded in 1998 and headquartered in West Palm Beach, Florida with operational presence in Boston, Massachusetts, the company targets physicians, prescribers, and healthcare providers — particularly those without an EHR/EMR system — who require electronic prescribing capabilities for both standard medications and Schedule II-V controlled substances. The flagship TreatRx platform is certified through Surescripts for e-prescribing network connectivity and through the Drummond Group for EPCS (Electronic Prescribing of Controlled Substances), and is HIPAA and SOC 2 Type 2 compliant.

The platform's technical architecture rests on direct integration with the Surescripts pharmacy network and with Pharmacy Benefit Managers (PBMs) for real-time eligibility and formulary data, supplemented by a curated drug reference database of 60,000+ medications and a year of nationwide medication history. Core functional capabilities include real-time prescription benefit display, drug-drug and drug-allergy interaction alerts, weight-based pediatric dosing, pharmacy-initiated refill management, formulary customization, and an SMS-delivered pharmacy cost-saving program that activates patient co-pay assistance at the point of prescribing without provider intervention. The product is accessible from any device via a web application with no installation required.

Bravado Health operates a product-led, self-serve go-to-market motion. Providers can sign up directly through the ayva.bravadohealth.com website, complete onboarding in under 24 hours, and subscribe to monthly tiers — a base ePrescribing plan and a premium upgrade that adds controlled-substance prescribing capability. The company charges no setup or integration fees and has not publicly disclosed price points. It employs 11–50 people, has raised approximately $1.33 million in disclosed funding (April 2021), serves only the US market, and has not disclosed revenue. No enterprise customer logos are named; the customer base appears to consist of distributed independent and small-practice prescribers acquired through self-serve channels.

Short descriptiontext

Bravado Health (PRN Software, LLC; brands TreatRx, DoseSpot) provides a standalone, cloud-based ePrescribing platform — including EPCS for Schedule II-V controlled substances — targeted at US healthcare providers without EHR/EMR systems, sold via self-serve monthly subscriptions with no setup fees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWest Palm Beach, United States
HQ citystring
West Palm Beach
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electronic prescribing software, eprescribing platform, controlled substance prescribing, prescription benefit management, healthcare SaaS
Industry3 codes
1ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history)
CodeHLALAIADPrimaryYes
2Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance
CodeHLACAKAJPrimaryNo
3Medication Pricing, Copay Assistance & Patient Financial Support Tools
CodeHLACAKANPrimaryNo
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Electronic Prescribing (ePrescribing) Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Subscription - Base Tier
TypeSubscription Recurring
Description

Monthly subscription with no hidden fees providing core ePrescribing functionality including prescription benefit information and price transparency at point of prescribing. Cancel at any time.

treatrx.dosespot.com
2Subscription - Controlled Substances Upgrade
TypeSubscription Recurring
Description

Upgrade subscription tier to include prescribing of Schedule II-V controlled substances, providing higher-tier functionality for providers who need EPCS capabilities.

treatrx.dosespot.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details2 tiers
1Base subscription with standard ePrescribing features
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly subscription with no hidden fees; cancel at any time. Includes prescription benefit information and price transparency at point of prescribing.

treatrx.dosespot.com
2Premium subscription with controlled substances (EPCS)
ModelSubscriptionBilling cadenceMonthly
Notes

Upgrade subscription to include prescribing of Schedule II-V controlled substances. No cost integration and setup.

treatrx.dosespot.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

TreatRx is Bravado Health's standalone, cloud-based electronic prescribing (ePrescribing) platform that enables U.S. healthcare providers to electronically write prescriptions for both non-controlled and Schedule II-V controlled substances without requiring EHR/EMR integration or in-house technical staff. The platform delivers real-time prescription benefit and price transparency, drug reference, formulary, clinical decision support, pharmacy-initiated refill management, and SMS-activated patient co-pay assistance directly at the point of prescribing, sold via monthly subscription tiers with an upgrade path for EPCS (controlled substance) capability.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 2/3 of prescribers would likely change Rx to a drug better covered by patient's benefit plan or not requiring prior authorization
+2 more records
Product overview1 text field

TreatRx is a standalone ePrescribing solution offered by Bravado Health (operated by PRN Software, LLC) that enables healthcare providers to electronically prescribe medications including Schedule II-V controlled substances. The platform integrates real-time prescription benefit information, price transparency, and pharmacy cost-saving programs directly at the point of prescribing. The core TreatRx platform is supplemented by optional add-ons for controlled substance prescribing (EPCS) and specialized modules for eligibility/formulary access, medication history, clinical decision support, prescription management, and search functionality. Pricing is offered through monthly subscription tiers with no cost integration and setup.

Product and service1 record
1TreatRx
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Surescripts provides the network infrastructure for e-prescribing connectivity, enabling TreatRx to access pharmacy networks and transmit prescriptions electronically. TreatRx is certified through Surescripts for e-prescribing functionality.

Strategic tierCoreTypeTechnology or Integration
Description

Drummond Group provides EPCS (Electronic Prescribing of Controlled Substances) certification testing services, verifying that TreatRx meets security standards for prescribing Schedule II-V controlled substances electronically.

Strategic tierCoreTypeTechnology or Integration
Description

PBMs provide real-time eligibility and formulary data integrated into TreatRx, enabling providers to view patient coverage, alternative medications, and cost information at point of prescribing.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Operated by the same parent (Bravado Health / PRN Software, LLC), DoseSpot provides embedded ePrescribing for digital health platforms. It is the closest comparable product to TreatRx within the same corporate family, targeting digital-health-vendor integrations versus TreatRx's standalone prescriber positioning.

TypeDirect peer
Description

DrFirst offers ePrescribing, EPCS, and medication management solutions to providers and EHR vendors. It directly competes with TreatRx in standalone and integrated ePrescribing, including certified EPCS and real-time benefit functionality.

TypeDirect peer
Description

iPrescribe is a standalone, mobile-first ePrescribing app with EPCS capabilities targeting independent prescribers. It competes head-to-head with TreatRx for the same small-practice, no-EHR prescriber segment.

TypeDirect peer
Description

NewCrop provides electronic prescribing and medication management technology integrated into EHRs and health systems. It overlaps with TreatRx in core ePrescribing and EPCS, typically serving larger integrated customers.

TypeBroad incumbent
Description

Practice Fusion is a cloud-based EHR for small and independent practices with bundled ePrescribing and EPCS. It competes indirectly with TreatRx by offering ePrescribing as part of a broader EHR suite aimed at the same small-practice customer.

TypeBroad incumbent
Description

Epic is the dominant enterprise EHR, with deeply embedded ePrescribing and EPCS modules used by large hospital systems and academic medical centers. As a broad incumbent, it represents the long-term competitive ceiling for standalone tools like TreatRx.

TypeBroad incumbent
Description

Oracle Health offers enterprise EHR platforms with integrated ePrescribing and EPCS across large health systems. It is a broad incumbent competitor whose embedded modules reduce the addressable market for standalone ePrescribing vendors.

TypeOthers
Description

Surescripts operates the nationwide ePrescribing network that TreatRx depends on for pharmacy connectivity, eligibility, and medication history. While not a direct competitor, it is a critical infrastructure provider whose terms and certifications directly shape TreatRx's economics.

TypeEmerging player
Description

Arrive Health delivers real-time prescription benefit and price transparency tools integrated into EHRs and provider workflows. It competes with TreatRx's RTPB feature and is extending into prescribing workflow automation—an emerging adjacent competitor.

TypeOthers
Description

GoodRx is a consumer-facing prescription savings platform that overlaps with TreatRx's pharmacy cost-saving and copay assistance functionality. While not an ePrescribing competitor, it competes for the same patient affordability and adherence value proposition.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bravado Health

Electronic Prescribing (ePrescribing) Softwarebravadohealth.com

Bravado Health (PRN Software, LLC; brands TreatRx, DoseSpot) provides a standalone, cloud-based ePrescribing platform — including EPCS for Schedule II-V controlled substances — targeted at US healthcare providers without EHR/EMR systems, sold via self-serve monthly subscriptions with no setup fees.

What Bravado Health does

Bravado Health (operating through its legal entity PRN Software, LLC and trade names TreatRx and DoseSpot) is a US-based healthcare IT company that provides a standalone, cloud-based electronic prescribing (ePrescribing) platform. Founded in 1998 and headquartered in West Palm Beach, Florida with operational presence in Boston, Massachusetts, the company targets physicians, prescribers, and healthcare providers — particularly those without an EHR/EMR system — who require electronic prescribing capabilities for both standard medications and Schedule II-V controlled substances. The flagship TreatRx platform is certified through Surescripts for e-prescribing network connectivity and through the Drummond Group for EPCS (Electronic Prescribing of Controlled Substances), and is HIPAA and SOC 2 Type 2 compliant.

The platform's technical architecture rests on direct integration with the Surescripts pharmacy network and with Pharmacy Benefit Managers (PBMs) for real-time eligibility and formulary data, supplemented by a curated drug reference database of 60,000+ medications and a year of nationwide medication history. Core functional capabilities include real-time prescription benefit display, drug-drug and drug-allergy interaction alerts, weight-based pediatric dosing, pharmacy-initiated refill management, formulary customization, and an SMS-delivered pharmacy cost-saving program that activates patient co-pay assistance at the point of prescribing without provider intervention. The product is accessible from any device via a web application with no installation required.

Bravado Health operates a product-led, self-serve go-to-market motion. Providers can sign up directly through the ayva.bravadohealth.com website, complete onboarding in under 24 hours, and subscribe to monthly tiers — a base ePrescribing plan and a premium upgrade that adds controlled-substance prescribing capability. The company charges no setup or integration fees and has not publicly disclosed price points. It employs 11–50 people, has raised approximately $1.33 million in disclosed funding (April 2021), serves only the US market, and has not disclosed revenue. No enterprise customer logos are named; the customer base appears to consist of distributed independent and small-practice prescribers acquired through self-serve channels.

Bravado Health firmographics

Firmographics
Name
Bravado Health
Legal name
PRN Software, LLC
Website
https://bravadohealth.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
11–50 employees
Short description
Bravado Health (PRN Software, LLC; brands TreatRx, DoseSpot) provides a standalone, cloud-based ePrescribing platform — including EPCS for Schedule II-V controlled substances — targeted at US healthcare providers without EHR/EMR systems, sold via self-serve monthly subscriptions with no setup fees.
Ownership category
akta.pro rank

Bravado Health industry classification

Industry
Product category
Electronic Prescribing (ePrescribing) Software
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)
akta.pro secondary industries
Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance (HLACAKAJ), Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)

Keywords

  • Electronic prescribing software
  • Eprescribing platform
  • Controlled substance prescribing
  • Prescription benefit management
  • Healthcare SaaS

Where Bravado Health is headquartered

Location

Headquarters

HQ city
West Palm Beach
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bravado Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Subscription - Base Tier: Monthly subscription with no hidden fees providing core ePrescribing functionality including prescription benefit information and price transparency at point of prescribing. Cancel at any time.
  2. Subscription - Controlled Substances Upgrade: Upgrade subscription tier to include prescribing of Schedule II-V controlled substances, providing higher-tier functionality for providers who need EPCS capabilities.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyBase subscription with standard ePrescribing features
SubscriptionMonthlyPremium subscription with controlled substances (EPCS)

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Bravado Health product offering

Product offering

Core offering

TreatRx is Bravado Health's standalone, cloud-based electronic prescribing (ePrescribing) platform that enables U.S. healthcare providers to electronically write prescriptions for both non-controlled and Schedule II-V controlled substances without requiring EHR/EMR integration or in-house technical staff. The platform delivers real-time prescription benefit and price transparency, drug reference, formulary, clinical decision support, pharmacy-initiated refill management, and SMS-activated patient co-pay assistance directly at the point of prescribing, sold via monthly subscription tiers with an upgrade path for EPCS (controlled substance) capability.

Product overview

TreatRx is a standalone ePrescribing solution offered by Bravado Health (operated by PRN Software, LLC) that enables healthcare providers to electronically prescribe medications including Schedule II-V controlled substances. The platform integrates real-time prescription benefit information, price transparency, and pharmacy cost-saving programs directly at the point of prescribing. The core TreatRx platform is supplemented by optional add-ons for controlled substance prescribing (EPCS) and specialized modules for eligibility/formulary access, medication history, clinical decision support, prescription management, and search functionality. Pricing is offered through monthly subscription tiers with no cost integration and setup.

Differentiator

Problem solved

Functional benefit

Products and services

  • TreatRx

Quantifiable outcome

  • 2/3 of prescribers would likely change Rx to a drug better covered by patient's benefit plan or not requiring prior authorization
  • +2 more outcomes

Companies that use Bravado Health

Customer profile

Segments1 record

Ideal customer profiles1 record

Bravado Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature8 records

Bravado Health partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • SurescriptscoreTechnology or IntegrationSurescripts provides the network infrastructure for e-prescribing connectivity, enabling TreatRx to access pharmacy networks and transmit prescriptions electronically. TreatRx is certified through Surescripts for e-prescribing functionality.
  • Drummond GroupcoreTechnology or IntegrationDrummond Group provides EPCS (Electronic Prescribing of Controlled Substances) certification testing services, verifying that TreatRx meets security standards for prescribing Schedule II-V controlled substances electronically.
  • Pharmacy Benefit Managers (PBMs)coreTechnology or IntegrationPBMs provide real-time eligibility and formulary data integrated into TreatRx, enabling providers to view patient coverage, alternative medications, and cost information at point of prescribing.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Bravado Health competitors and assessment

Company assessment

Direct peers

  • DoseSpot: Operated by the same parent (Bravado Health / PRN Software, LLC), DoseSpot provides embedded ePrescribing for digital health platforms. It is the closest comparable product to TreatRx within the same corporate family, targeting digital-health-vendor integrations versus TreatRx's standalone prescriber positioning.
  • DrFirst: DrFirst offers ePrescribing, EPCS, and medication management solutions to providers and EHR vendors. It directly competes with TreatRx in standalone and integrated ePrescribing, including certified EPCS and real-time benefit functionality.
  • iPrescribe (by eHealth Solutions): iPrescribe is a standalone, mobile-first ePrescribing app with EPCS capabilities targeting independent prescribers. It competes head-to-head with TreatRx for the same small-practice, no-EHR prescriber segment.
  • NewCrop: NewCrop provides electronic prescribing and medication management technology integrated into EHRs and health systems. It overlaps with TreatRx in core ePrescribing and EPCS, typically serving larger integrated customers.

Broad incumbents

  • Practice Fusion: Practice Fusion is a cloud-based EHR for small and independent practices with bundled ePrescribing and EPCS. It competes indirectly with TreatRx by offering ePrescribing as part of a broader EHR suite aimed at the same small-practice customer.
  • Epic Systems: Epic is the dominant enterprise EHR, with deeply embedded ePrescribing and EPCS modules used by large hospital systems and academic medical centers. As a broad incumbent, it represents the long-term competitive ceiling for standalone tools like TreatRx.
  • Oracle Health (formerly Cerner): Oracle Health offers enterprise EHR platforms with integrated ePrescribing and EPCS across large health systems. It is a broad incumbent competitor whose embedded modules reduce the addressable market for standalone ePrescribing vendors.

Others

  • Surescripts: Surescripts operates the nationwide ePrescribing network that TreatRx depends on for pharmacy connectivity, eligibility, and medication history. While not a direct competitor, it is a critical infrastructure provider whose terms and certifications directly shape TreatRx's economics.
  • GoodRx: GoodRx is a consumer-facing prescription savings platform that overlaps with TreatRx's pharmacy cost-saving and copay assistance functionality. While not an ePrescribing competitor, it competes for the same patient affordability and adherence value proposition.

Emerging players

  • Arrive Health: Arrive Health delivers real-time prescription benefit and price transparency tools integrated into EHRs and provider workflows. It competes with TreatRx's RTPB feature and is extending into prescribing workflow automation—an emerging adjacent competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bravado Health social profiles

Digital presence

Bravado Health compliance and trust

Trust signal

Compliance4 records

Bravado Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bravado Health leadership team

Management profile

Number of profiles

Profiles7 records

Bravado Health funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bravado Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bravado Health

What does Bravado Health do?

TreatRx is Bravado Health's standalone, cloud-based electronic prescribing (ePrescribing) platform that enables U.S. healthcare providers to electronically write prescriptions for both non-controlled and Schedule II-V controlled substances without requiring EHR/EMR integration or in-house technical staff. The platform delivers real-time prescription benefit and price transparency, drug reference, formulary, clinical decision support, pharmacy-initiated refill management, and SMS-activated patient co-pay assistance directly at the point of prescribing, sold via monthly subscription tiers with an upgrade path for EPCS (controlled substance) capability.

When was Bravado Health founded?

Bravado Health was founded in 1998. It employs 11 to 50 people.

Where is Bravado Health based?

Bravado Health is headquartered in West Palm Beach, United States, in the North America region.

How does Bravado Health make money?

Two revenue lines are on record. Subscription - Base Tier is the primary driver. The others are subscription - Controlled Substances Upgrade.

Who are Bravado Health's main competitors?

Direct peers on record are DoseSpot, DrFirst, iPrescribe (by eHealth Solutions) and NewCrop. Broad incumbents are Practice Fusion, Epic Systems and Oracle Health (formerly Cerner). Others are Surescripts and GoodRx. Arrive Health is listed as an emerging player.

Does Bravado Health have an API?

No public API is recorded for Bravado Health.

What industry is Bravado Health in?

Bravado Health's product category is Electronic Prescribing (ePrescribing) Software. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history), with a secondary code of HLACAKAJ, Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance. Its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DosespotDoseSpot Acquires TreatRx from Bravado HealthDoseSpot has acquired TreatRx, the ePrescribing business of Bravado Health, to expand its capabilities in providing standalone ePrescribing solutions. This acquisition allows DoseSpot to integrate Bravado's technology and expertise into its platform, aiming to enhance practice efficiency and compliance for customers.PR NewswireAyva Ortho: The future of virtual perioperative care is hereBravado Health introduced Ayva Ortho, a new virtual perioperative service designed to lower costs for orthopedic practices by assisting case managers and clinicians. The platform leverages automation to improve patient engagement, streamline pre- and post-operative care, and allow providers to expand their caseloads efficiently.PR NewswireBetter Life Partners taps Bravado Health to help curb community's opioid crisisBravado Health has entered into a partnership with Better Life Partners to provide e-prescribing technology aimed at improving treatment for opioid use disorder. This collaboration utilizes Bravado Health's Treat API to enable faster, more efficient, and affordable medication access for Better Life Partners' patients in South Florida.PR NewswireBravado Health partners with Palmdale Oil Company to screen employees for COVID-19Bravado Health announced a partnership with Palmdale Oil Company to implement a daily COVID-19 symptom screening program for Palmdale Oil employees across Florida. Under the program, employees record their health status and temperature via smartphone before work, with any concerning results triggering stay-home protocols and manager notification. Palmdale Oil, which provides fuel services to essential industries in South Florida, will use Bravado Health's screening tool to maintain safer working conditions for employees and customers.PR NewswireBravado Health partners with K-Rain to screen employees for COVID-19Bravado Health announced a partnership with K-Rain to implement daily COVID-19 symptom screening for the irrigation manufacturer's employees in the United States and Dominican Republic. Under the program, employees record their health status and temperature via smartphone before work each day, with any abnormal readings triggering a stay-home directive and notifying a safety manager. The screening tool is part of Bravado Health's COVID-19 program aimed at helping businesses reduce infection spread while maintaining operations.PR NewswireBravado Health Partners with FordCom to Screen Critical Infrastructure Workers for COVID-19Bravado Health has partnered with FordCom Tower Service to implement a daily COVID-19 symptom screening program for FordCom's essential critical infrastructure workers who build and maintain wireless communication towers in the Midwest. Under the program, employees record their health status and temperature on their smartphones each day before work, with out-of-range results triggering a stay-home directive and notification to a safety manager. The partnership aims to help FordCom maintain safer operations for its workforce while continuing to provide essential telecom services during the pandemic.PR NewswireBravado Health releases COVID-19 tool to help hospitals and businesses connect with patients and employeesBravado Health released a COVID-19 screening and education tool for hospitals and businesses, based on CDC guidance. The tool lets users answer symptom questions and receive CDC recommendations on social distancing, self-isolation, and hygiene. It aims to reduce exposure risk by helping people stay connected from home.PR NewswireChristopher Lazzara joins Bravado Health's board of directorsChristopher Lazzara joined Bravado Health's board of directors on Oct. 15, 2019. He previously served as CEO of Neptune Research, which merged with Clock Spring, and now sits on the combined Clockspring-NRI board. He also chairs NRI and holds several U.S. patents.PR NewswireBravado Health launches new patient discharge productBravado Health launched Ayva Discharge, its first product in the Ayva patient engagement platform, on April 9, 2019. The web-based application provides discharge materials including evidence-based instructions, electronic prescriptions, and referrals. The platform will focus on post-visit patient experience, with Ayva Engage launching in June 2019.PR NewswireBravado Health to expand patient engagement portfolioBravado Health, a health IT company headquartered in West Palm Beach, Florida, announced the expansion of its product portfolio with the launch of the Ayva patient education and engagement platform. The platform will release two products in 2019: Ayva Discharge in March 2019 and Ayva Engage in June 2019, designed to support post-visit patient experiences and improve outcomes. The company stated that the new platform extends their reach beyond point-of-care to securely connect with patients after visits, bridging gaps in the continuum of care.